S. Korea Scientists Develop Flu Vaccine Delivered Under Tongue
This article was originally published in PharmAsia News
Medical researchers in South Korea report success in providing a vaccination with a pill under the tongue instead of using a needle, or ingesting or inhaling the drug. The research team at the International Vaccine Institute in Seoul tested a flu vaccine on mice and said they developed a healthy immune response in their lungs and repelled a more severe form of the virus later. The leading researcher said the method eliminates a risk of an antigen redirection to the central nervous system, a risk common to vaccines delivered intravenously. (Click here for more
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.